{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:34:28Z","timestamp":1791340468624,"version":"4.3.1"},"reference-count":26,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Anaplastic large cell lymphoma (ALCL) designates a heterogeneous group of CD30+ (systemic or primary cutaneous) peripheral T-cell lymphomas (PTCLs). A subgroup of systemic ALCL is transformed by anaplastic lymphoma kinase (ALK). We compared 24 ALK+, 15 ALK- systemic, and 7 cutaneous ALCLs with 29 nonanaplastic PTCLs in terms of T-cell receptor (TCR) rearrangements, expression of TCRs and TCR-associated molecules (CD3, ZAP-70 [zeta-associated protein 70]). Despite their frequent clonal rearrangement for TCR\u03b2, only 2 (4%) of 47 ALCLs expressed TCR\u03b2 protein, whereas TCRs were detected on 27 of 29 nonanaplastic PTCLs. Moreover, both TCR\u03b2+ ALCLs lacked CD3 and ZAP-70 (ie, molecules indispensable for the transduction of cognate TCR signals). Defective expression of TCRs is a common characteristic of all types of ALCL, which may contribute to the dysregulation of intracellular signaling pathways controlling T-cell activation and survival. This molecular hallmark of ALCL is analogous to defective immunoglobulin expression distinguishing Hodgkin lymphoma from other B-cell lymphomas. (Blood. 2004; 104:3358-3360)<\/jats:p>","DOI":"10.1182\/blood-2004-03-1037","type":"journal-article","created":{"date-parts":[[2004,8,6]],"date-time":"2004-08-06T00:25:46Z","timestamp":1091751946000},"page":"3358-3360","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":167,"title":["Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling"],"prefix":"10.1182","volume":"104","author":[{"given":"Irina","family":"Bonzheim","sequence":"first","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Geissinger","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Roth","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zettl","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Konrad","family":"Mu\u0308ller-Hermelink","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ru\u0308diger","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, University of Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222311055300_REF1","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001."},{"key":"2020021222311055300_REF2","doi-asserted-by":"crossref","unstructured":"Weisenburger DD, Anderson JR, Diebold J, et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Am J Hematol. 2001;67: 172-178.","DOI":"10.1002\/ajh.1102"},{"key":"2020021222311055300_REF3","doi-asserted-by":"crossref","unstructured":"Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas. Semin Hematol. 2003;40: 244-256.","DOI":"10.1016\/S0037-1963(03)00138-0"},{"key":"2020021222311055300_REF4","doi-asserted-by":"crossref","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17: 2257-2317.","DOI":"10.1038\/sj.leu.2403202"},{"key":"2020021222311055300_REF5","doi-asserted-by":"crossref","unstructured":"Nel AE. T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol. 2002;109: 758-770.","DOI":"10.1067\/mai.2002.124259"},{"key":"2020021222311055300_REF6","doi-asserted-by":"crossref","unstructured":"Pitcher LA, van Oers NS. T-cell receptor signal transmission: who gives an ITAM? Trends Immunol. 2003;24: 554-560.","DOI":"10.1016\/j.it.2003.08.003"},{"key":"2020021222311055300_REF7","doi-asserted-by":"crossref","unstructured":"Chott A, Kaserer K, Augustin I, et al. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol. 1990;14: 439-448.","DOI":"10.1097\/00000478-199005000-00003"},{"key":"2020021222311055300_REF8","doi-asserted-by":"crossref","unstructured":"Agnarsson BA, Kadin ME. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol. 1988;12: 264-274.","DOI":"10.1097\/00000478-198804000-00002"},{"key":"2020021222311055300_REF9","doi-asserted-by":"crossref","unstructured":"Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol. 1993;17: 859-868.","DOI":"10.1097\/00000478-199309000-00001"},{"key":"2020021222311055300_REF10","doi-asserted-by":"crossref","unstructured":"Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma. A single disease with a broad spectrum of morphology. Blood. 1998;91: 2076-2084.","DOI":"10.1182\/blood.V91.6.2076"},{"key":"2020021222311055300_REF11","unstructured":"Barry TS, Hwang HC, Bacchi CE, et al. ZAP-70 expression in B and T-cell lymphomas: an immunohistochemical study of 266 cases [abstract]. Mod Pathol. 2004;17: 240."},{"key":"2020021222311055300_REF12","doi-asserted-by":"crossref","unstructured":"Krena\u0301cs L, Wellmann A, Sorbara L, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood. 1997;89: 980-989.","DOI":"10.1182\/blood.V89.3.980"},{"key":"2020021222311055300_REF13","doi-asserted-by":"crossref","unstructured":"Ohshima K, Kikuchi M, Masuda Y, et al. Genotypic and immunophenotypic analysis of anaplastic large cell lymphoma (Ki-1 lymphoma). Pathol Res Pract. 1990;186: 582-588.","DOI":"10.1016\/S0344-0338(11)80221-9"},{"key":"2020021222311055300_REF14","doi-asserted-by":"crossref","unstructured":"Foss HD, Anagnostopoulos I, Araujo I, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood. 1996;88: 4005-4011.","DOI":"10.1182\/blood.V88.10.4005.bloodjournal88104005"},{"key":"2020021222311055300_REF15","doi-asserted-by":"crossref","unstructured":"Barry TS, Jaffe ES, Sorbara L, Raffeld M, Pittaluga S. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol. 2003;27: 1513-1522.","DOI":"10.1097\/00000478-200312000-00003"},{"key":"2020021222311055300_REF16","doi-asserted-by":"crossref","unstructured":"Fischer P, Nacheva E, Mason DY, et al. A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood. 1988;72: 234-240.","DOI":"10.1182\/blood.V72.1.234.234"},{"key":"2020021222311055300_REF17","doi-asserted-by":"crossref","unstructured":"Morgan R, Smith SD, Hecht BK, et al. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood. 1989;73: 2155-2164.","DOI":"10.1182\/blood.V73.8.2155.2155"},{"key":"2020021222311055300_REF18","doi-asserted-by":"crossref","unstructured":"Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184: 1495-1505.","DOI":"10.1084\/jem.184.4.1495"},{"key":"2020021222311055300_REF19","doi-asserted-by":"crossref","unstructured":"Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1\/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97: 496-501.","DOI":"10.1182\/blood.V97.2.496"},{"key":"2020021222311055300_REF20","doi-asserted-by":"crossref","unstructured":"Pai SY, Truitt ML, Ting CN, Leiden JM, Glimcher LH, Ho IC. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity. 2003;19: 863-875.","DOI":"10.1016\/S1074-7613(03)00328-5"},{"key":"2020021222311055300_REF21","doi-asserted-by":"crossref","unstructured":"Bai RY, Dieter P, Peschel C, Morris SW, Duyster J. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol. 1998;18: 6951-6961.","DOI":"10.1128\/MCB.18.12.6951"},{"key":"2020021222311055300_REF22","unstructured":"Frump JR, Henrickson SE, Rosenwald A, et al. Microarray analysis demonstrates differences in the pathogenesis of ALK+ and ALK-anaplastic large cell lymphomas [abstract]. Mod Pathol. 2004;17: 248."},{"key":"2020021222311055300_REF23","doi-asserted-by":"crossref","unstructured":"Bai RY, Ouyang T, Miething C, Morris SW, Peschel C, Duyster J. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase\/Akt antiapoptotic signaling pathway. Blood. 2000;96: 4319-4327.","DOI":"10.1182\/blood.V96.13.4319"},{"key":"2020021222311055300_REF24","doi-asserted-by":"crossref","unstructured":"Zamo A, Chiarle R, Piva R, et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 2002;21: 1038-1047.","DOI":"10.1038\/sj.onc.1205152"},{"key":"2020021222311055300_REF25","doi-asserted-by":"crossref","unstructured":"Zhang Q, Raghunath PN, Xue L, et al. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T\/null-cell lymphoma. J Immunol. 2002;168: 466-474.","DOI":"10.4049\/jimmunol.168.1.466"},{"key":"2020021222311055300_REF26","doi-asserted-by":"crossref","unstructured":"Lee IH, Li WP, Hisert KB, Ivashkiv LB. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT) 5 activation during T cell receptor-mediated feedback inhibition of T cell expansion. J Exp Med. 1999;190: 1263-1274.","DOI":"10.1084\/jem.190.9.1263"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3358\/1703229\/zh802204003358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3358\/1703229\/zh802204003358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T03:31:25Z","timestamp":1581564685000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/10\/3358\/18733\/Anaplastic-large-cell-lymphomas-lack-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,15]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-03-1037","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,15]]}}}